Nima Farzan insider trades: Keros Therapeutics (KROS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Nima reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | KROS | ↓ Sell | 2,625 | $10.73 | $28K | Direct | Jun 8, 2026 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KROS insiders
Open-market trades in the last 12 months
About Nima Farzan's insider trades
Nima Farzan is an insider at Keros Therapeutics (KROS). Since Jun 4, 2026, Nima has reported no open-market purchases and 1 sale worth $28K on SEC Form 4. In the last 12 months: 1 sale ($28K).
Their filings also include grants and awards (9 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KROS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.